Perelel Secures $27M Growth Funding Led by Prelude Growth Partners

Why It Matters

The infusion of growth capital positions Perelel to scale its evidence‑based offerings in a rapidly expanding women’s health supplement market, potentially reshaping competitive dynamics and attracting further strategic partnerships.

Deal Summary

Los Angeles‑based supplement maker Perelel announced a $27 million growth‑stage financing round. The round was led by Prelude Growth Partners with participation from existing backers Unilever Ventures, Willow Growth Partners and Selva Ventures, aiming to expand its clinically‑proven women’s health product line.